contenthubtop
Newsroom Search Center

Search Center

Category

Only the scope(s):
Improve your searches with search tips
contenthubbottom

Support

#
 

ePress Kits

Information packets where you will find everything you need from corporate logos to tradeshow related press releases.

 
 
OSRAM SYLVANIA Helps Better Diagnose Ear Canal with New Osram ITOS O-03100 LED Lamp
Only FDA Approved LED Replacement Lamp Offers Longer Life, Enhanced Brightness.
April 5, 2013
 
use default URL
 

Danvers, Mass.– North American lighting leader OSRAM SYLVANIA today unveiled the OSRAM ITOS® O-03100 LED lamp for otoscopes. Delivering higher lumens than both traditional halogen lamps and other LED light sources, the ITOS O-03100 allows superior visualization of the inner ear which can help better diagnose patients. Manufactured in the United States, the LED retrofit lamp fits the most popular Welch Allyn otoscope devices and requires no modification.

As the only FDA approved LED replacement lamp, the ITOS O-03100 is up to 70 percent brighter than traditional halogen light sources. Enhanced brightness can make a difference as indicated by a study on Acute Otitis Media conducted by the University of Rochester Medical Center and reported by the American Academy of Family Physicians in April 2000. The study indicated that a brighter light source was key to accurate visualization of the tympanic membrane and proper diagnoses. 

“A doctor is only able to properly diagnose a patient if they have all the facts, and with the human ear, that means being able to see inside as best as possible,” said Jack Burwick, product marketing manager, OSRAM SYLVANIA. “The OSRAM ITOS O-03100 LED lamp for otoscopes offers high quality light which means medical professionals are able to better examine their patients and make the best call.”

Longer Life and Better, Consistent Light

Halogen lamps with life cycles of only 10-20 hours pose greater potential for reduced light output towards the end of their life cycle. The ITOS O-03100 LED lamp has an average lifetime of over 25,000 hours, exceeding life over a traditional halogen lamp by a factor of more than 1,000, which means far fewer lamp replacements. The gold-plated lamp body provides excellent thermal conductivity and corrosion resistance, both critical to supporting the extended lifetime.

Unlike other options, the ITOS O-03100 LED lamp delivers white light of the same color temperature and excellent color rendering as traditional halogen lamps. However, traditional halogen lamps will undergo a shift in color temperature during dimming or as the battery discharges, potentially leading to different visualizations of the inner ear. The OSRAM ITOS O-03100 LED lamp maintains a steady color temperature during dimming and battery discharge, with minimal color shift. Switching to the ITOS O-03100 lamp provides the same color quality, but with greater consistency. This translates to doctors being able to more accurately see inside a patient’s ear and identify any potential problems over the life of the lamp.

A video and more information about the features and performance specifications of the OSRAM ITOS-03100 LED lamp can be found on at www.sylvania.com/ITOS. 

 

About OSRAM SYLVANIA
OSRAM SYLVANIA is a leader in lighting solutions and services, specializing in innovative design and energy saving technology. The company sells products for homes, businesses and vehicles primarily under the SYLVANIA brand name, and also under the OSRAM brand. Headquartered in Danvers, Mass., OSRAM SYLVANIA is the North American operation of OSRAM GmbH. For more information, visit www.sylvania.com or follow us on Facebook and Twitter. 

DISCLAIMER
"This document constitutes neither an offer to sell nor a solicitation to buy or subscribe for securities. Any such offer will be made solely on the basis of the Securities Prospectus yet to be approved by the German Financial Supervisory Authority (BaFin) and published thereafter. The information legally required to be provided to investors will be contained only in the Securities Prospectus. The information contained herein is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions of any State of the United States of America or the District of Columbia) and must not be distributed to U.S. persons (as defined in Regulation S under the U.S. Securities Act of 1933, as amended ("Securities Act")) or publications with a general circulation in the United States of America. This document is not an offer of securities for sale in the United States of America. The securities have not been and will not be registered under the Securities Act and may not be offered or sold in the United States of America absent registration or an exemption from registration under the Securities Act. The Issuer does not intend to register any portion of the offering in the United States of America or to conduct a public offering of the securities in the United States of America. This document is not an offer of securities for sale in the United Kingdom, Canada, Japan or Australia."